15.451 articles found

Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.

Gao L, Díaz-Corrales FJ, Carrillo F, Díaz-Martín J, Caceres-Redondo MT, Carballo M, Palomino A, López-Barneo J, Mir P.

Acta Neurol Scand · 2010-01-19

DOI: 10.1111/j.1600-0404.2009.01253.xPMID: 20085561

An image analysis pipeline for the semi-automated analysis of clinical fMRI images based on freely available software.

Karmonik C, York M, Grossman R, Kakkar E, Patel K, Haykal H, King D.

Comput Biol Med · 2010-01-13

DOI: 10.1016/j.compbiomed.2009.12.003PMID: 20074720

Evidence for motor learning in Parkinson's disease: acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues.

Rochester L, Baker K, Hetherington V, Jones D, Willems AM, Kwakkel G, Van Wegen E, Lim I, Nieuwboer A.

Brain Res · 2010-01-11

DOI: 10.1016/j.brainres.2010.01.001PMID: 20064492

Clinical correlates of autonomic dysfunction in patients with Machado-Joseph disease.

França MC, D'Abreu A, Nucci A, Lopes-Cendes I.

Acta Neurol Scand · 2010-01-11

DOI: 10.1111/j.1600-0404.2009.01249.xPMID: 20070275

Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria.

Okubadejo NU, Ojo OO, Oshinaike OO.

BMC Neurol · 2010-01-05

DOI: 10.1186/1471-2377-10-1PMID: 20051133

Serum somatostatin in early-stage Parkinson's disease.

Shiraishi M, Kobayashi T, Watanabe H, Kamo T, Hasegawa Y.

Acta Neurol Scand · 2010-01-03

DOI: 10.1111/j.1600-0404.2009.01178.xPMID: 20055772

Clinical and PET imaging studies in Parkinson's disease motor and non-motor complications : serotonergic and dopamimergic mechanisms and applications in treatment

Politis M.

· 2010-01-01

Pre-clinical experimental models for tauopathies : assessment of novel treatments

Melis V.

· 2010-01-01

Predictive potential of pre-operative functional neuroimaging in patients treated with subthalamic stimulation.

Sestini S, Pupi A, Ammannati F, Ramat S, Sorbi S, Sciagrà R, Mansi L, Castagnoli A.

Eur J Nucl Med Mol Imaging · 2010-01-01

DOI: 10.1007/s00259-009-1198-6PMID: 19582450

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.

Lyons KE, Friedman JH, Hermanowicz N, Isaacson SH, Hauser RA, Hersh BP, Silver DE, Tetrud JW, Elmer LW, Parashos SA, Struck LK, Lew MF, Pahwa R.

Clin Neuropharmacol · 2010-01-01

DOI: 10.1097/wnf.0b013e3181b7926fPMID: 19855267

A positive influence of vision on motor symptoms during sensory attention focused exercise for Parkinson's disease.

Sage MD, Almeida QJ.

Mov Disord · 2010-01-01

DOI: 10.1002/mds.22886PMID: 19938164

The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.

Fleeman N, McLeod C, Bagust A, Beale S, Boland A, Dundar Y, Jorgensen A, Payne K, Pirmohamed M, Pushpakom S, Walley T, de Warren-Penny P, Dickson R.

Health Technol Assess · 2010-01-01

DOI: 10.3310/hta14030PMID: 20031087